Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s40364-018-0122-2.

Title:
Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential | Biomarker Research
Description:
Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase and a catalytic component of PRC2, catalyzes tri-methylation of histone H3 at Lys 27 (H3K27me3) to regulate gene expression through epigenetic machinery. EZH2 also functions both as a transcriptional suppressor and a transcriptional co-activator, depending on H3K27me3 or not and on the different cellular contexts. Unsurprisingly, numerous studies have highlighted the role of EZH2 in cancer development and progression. Through modulating critical gene expression, EZH2 promotes cell survival, proliferation, epithelial to mesenchymal, invasion, and drug resistance of cancer cells. The tumor suppressive effects of EZH2 are also identified. What is more, EZH2 has decisive roles in immune cells (for example, T cells, NK cells, dendritic cells and macrophages), which are essential components in tumor microenvironment. In this review, we aim to discuss the molecular functions of EZH2, highlight recent findings regarding the physiological functions and related regulation of EZH2 in cancer pathogenesis. Furthermore, we summarized and updated the emerging roles of EZH2 in tumor immunity, and current pre-clinical and clinical trials of EZH2 inhibitors in cancer therapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Education
  • Health & Fitness
  • Science

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We see no obvious way the site makes money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {πŸ”}

ezh, cancer, pubmed, article, google, scholar, cells, cas, cell, tumor, expression, central, histone, gene, activity, protein, prc, complex, hkme, breast, progression, functions, transcriptional, regulation, methyltransferase, proliferation, function, promotes, inhibitors, methylation, inhibition, identified, mutations, lymphoma, growth, directly, epigenetic, roles, genes, nat, studies, development, targeting, prostate, demonstrated, invasion, polycomb, glioblastoma, silencing, phosphorylation,

Topics {βœ’οΈ}

ifn-Ξ³-producing pd-1low cd8+ natural killer/t-cell lymphoma parp-mediated poly-adp ribosylation nk-based cancer immunotherapies article download pdf polycomb-dependent epigenetic landscape e3 ubiquitin ligase dna-damage repair deficiency adult t-cell leukemia hypoxia-induced hif-1Ξ± pd-l1 checkpoint blockade cdk5/fbw7-dependent ubiquitination disabled homolog2-interacting protein adoptive t-cell transfusion castration-resistant prostate cancer indicating mir-26a-ezh2 axis dual-faced molecule acting hifi-alpha activation underlies histone-modified hypomethylated gene ezh2-mediated epigenetic silencing enhances cisplatin-induced apoptosis cells-mediated tumor surveillance ubiquitination-dependent protein degradation mirna-mediated post-transcriptional regulation ezh2/forkhead box m1 triple-negative breast cancer activation ofhif-1Ξ± results type chemokines cxcl9 ezh2-mediated gene silencing cdk-mediated ezh2 phosphorylation increasing ezh2-mediated overexpression chromatin-modifying enzyme ezh2 exhibiting anti-tumor effects natural killer cells prc2-independent gene transactivation ezh2-mediated drug resistance ezh2-deficient tregs fail b-cell lymphomas histone h3k27 trimethylation mir-26a-ezh2 axis mds-mpn overlap disorders increase ezh2-mediated h3k27me3 jak2-mediated phosphorylation inhibit anti-tumor immunity mir-26a inhibits ezh2 full access ring1b ubiquitin ligases renal cell carcinoma weijian guo androgen receptor-target genes

Questions {❓}

  • EZH2 in cancer progression and potential application in cancer therapy: a friend or foe?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential
         description:Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase and a catalytic component of PRC2, catalyzes tri-methylation of histone H3 at Lys 27 (H3K27me3) to regulate gene expression through epigenetic machinery. EZH2 also functions both as a transcriptional suppressor and a transcriptional co-activator, depending on H3K27me3 or not and on the different cellular contexts. Unsurprisingly, numerous studies have highlighted the role of EZH2 in cancer development and progression. Through modulating critical gene expression, EZH2 promotes cell survival, proliferation, epithelial to mesenchymal, invasion, and drug resistance of cancer cells. The tumor suppressive effects of EZH2 are also identified. What is more, EZH2 has decisive roles in immune cells (for example, T cells, NK cells, dendritic cells and macrophages), which are essential components in tumor microenvironment. In this review, we aim to discuss the molecular functions of EZH2, highlight recent findings regarding the physiological functions and related regulation of EZH2 in cancer pathogenesis. Furthermore, we summarized and updated the emerging roles of EZH2 in tumor immunity, and current pre-clinical and clinical trials of EZH2 inhibitors in cancer therapy.
         datePublished:2018-03-09T00:00:00Z
         dateModified:2018-03-09T00:00:00Z
         pageStart:1
         pageEnd:10
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s40364-018-0122-2
         keywords:
            EZH2
            Epigenetic
            Histone H3 Lys27 trimethylation
            Cancer
            Polycomb repressive complex
            Biomedicine
            general
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40364-018-0122-2/MediaObjects/40364_2018_122_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40364-018-0122-2/MediaObjects/40364_2018_122_Fig2_HTML.gif
         isPartOf:
            name:Biomarker Research
            issn:
               2050-7771
            volumeNumber:6
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Lu Gan
               affiliation:
                     name:Fudan University Shanghai Cancer Center
                     address:
                        name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Fudan University
                     address:
                        name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Fudan University
                     address:
                        name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yanan Yang
               affiliation:
                     name:Fudan University Shanghai Cancer Center
                     address:
                        name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Fudan University
                     address:
                        name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qian Li
               affiliation:
                     name:Fudan University
                     address:
                        name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Fudan University
                     address:
                        name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yi Feng
               affiliation:
                     name:Fudan University
                     address:
                        name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Fudan University
                     address:
                        name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tianshu Liu
               affiliation:
                     name:Fudan University
                     address:
                        name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Fudan University
                     address:
                        name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Weijian Guo
               url:http://orcid.org/0000-0003-3078-3539
               affiliation:
                     name:Fudan University Shanghai Cancer Center
                     address:
                        name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Fudan University
                     address:
                        name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential
      description:Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase and a catalytic component of PRC2, catalyzes tri-methylation of histone H3 at Lys 27 (H3K27me3) to regulate gene expression through epigenetic machinery. EZH2 also functions both as a transcriptional suppressor and a transcriptional co-activator, depending on H3K27me3 or not and on the different cellular contexts. Unsurprisingly, numerous studies have highlighted the role of EZH2 in cancer development and progression. Through modulating critical gene expression, EZH2 promotes cell survival, proliferation, epithelial to mesenchymal, invasion, and drug resistance of cancer cells. The tumor suppressive effects of EZH2 are also identified. What is more, EZH2 has decisive roles in immune cells (for example, T cells, NK cells, dendritic cells and macrophages), which are essential components in tumor microenvironment. In this review, we aim to discuss the molecular functions of EZH2, highlight recent findings regarding the physiological functions and related regulation of EZH2 in cancer pathogenesis. Furthermore, we summarized and updated the emerging roles of EZH2 in tumor immunity, and current pre-clinical and clinical trials of EZH2 inhibitors in cancer therapy.
      datePublished:2018-03-09T00:00:00Z
      dateModified:2018-03-09T00:00:00Z
      pageStart:1
      pageEnd:10
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s40364-018-0122-2
      keywords:
         EZH2
         Epigenetic
         Histone H3 Lys27 trimethylation
         Cancer
         Polycomb repressive complex
         Biomedicine
         general
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40364-018-0122-2/MediaObjects/40364_2018_122_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40364-018-0122-2/MediaObjects/40364_2018_122_Fig2_HTML.gif
      isPartOf:
         name:Biomarker Research
         issn:
            2050-7771
         volumeNumber:6
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Lu Gan
            affiliation:
                  name:Fudan University Shanghai Cancer Center
                  address:
                     name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Fudan University
                  address:
                     name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Fudan University
                  address:
                     name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yanan Yang
            affiliation:
                  name:Fudan University Shanghai Cancer Center
                  address:
                     name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Fudan University
                  address:
                     name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qian Li
            affiliation:
                  name:Fudan University
                  address:
                     name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Fudan University
                  address:
                     name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yi Feng
            affiliation:
                  name:Fudan University
                  address:
                     name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Fudan University
                  address:
                     name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tianshu Liu
            affiliation:
                  name:Fudan University
                  address:
                     name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Fudan University
                  address:
                     name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Weijian Guo
            url:http://orcid.org/0000-0003-3078-3539
            affiliation:
                  name:Fudan University Shanghai Cancer Center
                  address:
                     name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Fudan University
                  address:
                     name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Biomarker Research
      issn:
         2050-7771
      volumeNumber:6
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Fudan University Shanghai Cancer Center
      address:
         name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University Shanghai Cancer Center
      address:
         name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University Shanghai Cancer Center
      address:
         name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Lu Gan
      affiliation:
            name:Fudan University Shanghai Cancer Center
            address:
               name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Fudan University
            address:
               name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Fudan University
            address:
               name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Yanan Yang
      affiliation:
            name:Fudan University Shanghai Cancer Center
            address:
               name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Fudan University
            address:
               name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Qian Li
      affiliation:
            name:Fudan University
            address:
               name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Fudan University
            address:
               name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Yi Feng
      affiliation:
            name:Fudan University
            address:
               name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Fudan University
            address:
               name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Tianshu Liu
      affiliation:
            name:Fudan University
            address:
               name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Fudan University
            address:
               name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Weijian Guo
      url:http://orcid.org/0000-0003-3078-3539
      affiliation:
            name:Fudan University Shanghai Cancer Center
            address:
               name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Fudan University
            address:
               name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
      name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
      name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
      name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
      name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
      name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
      name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
      name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
      name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
      name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China
      name:Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
      name:Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
      name:Department of Oncology, Shanghai Medical college, Fudan University, Shanghai, China

External Links {πŸ”—}(355)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

5.34s.